Despite Hosting mRNA Hub, South Africa Buys Vaccines From India – Highlighting Tension Between Price Pressures and Local Production 20/04/2023 Kerry Cullinan CAPE TOWN – South Africa’s Health Minister was somewhat embarrassed that his government’s decision to procure pneumococcal vaccines from an Indian company rather than local company Biovac became public during a high-level international meeting on the local production of mRNA vaccines in his country. South Africa’s procurement decision coincided with a meeting in Cape Town […] Continue reading -> As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
As Evidence Mounts That ‘War on Drugs’ Has Failed, Harm Reduction Advocates Call for New Policies 19/04/2023 Stefan Anderson Fifty years into the world “war on drugs”, the drugs are winning. Global levels of drug use and production, as well as drug-related deaths and incarcerations, are at all-time highs. Leading proponents of drug-policy reform who have gathered at the International Harm Reduction Conference in Melbourne this week say the evidence is in that it […] Continue reading -> WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Director General Calls on Countries to Protect Women’s Right to Abortion 18/04/2023 Megha Kaveri Two weeks after a Texas judge stirred controversy by banning a popular US abortion pill, WHO’s Director General has explicitly re-affirmed the organization’s support for abortion rights, stating that “women should always have the right to choose when it comes to their bodies and their health”. Dr Tedros Adhanom Ghebreyesus’ comments came just a day […] Continue reading -> WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
WHO’s New Leadership Team Is a Mixed Bag of Political Appointees and Specialists 17/04/2023 Elaine Ruth Fletcher Nearly a year after his appointment to a second term as WHO’s Director General, Tedros Adhanom Ghebreyesus has finished a revamp of his senior leadership team – keeping key loyalists in place, while adding new faces that are a clear nod to powerful member states such as China, France and Japan. But the new team […] Continue reading -> Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
Pharmaceutical CEOs to G7: Protect Intellectual Property Rights and Pathogen Access in WHO Pandemic Accord 14/04/2023 Stefan Anderson CEOs from the world’s largest pharmaceutical companies issued a call to G7 leaders on Friday to oppose the inclusion of intellectual property rights waivers and pathogen benefit sharing in the World Health Organization’s (WHO) pandemic treaty. In meetings with Japanese Prime Minister and chair of next month’s G7 summit Fumio Kishida this week, a delegation […] Continue reading -> Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
Abortion Pill Manufacturer Turns to US Supreme Court 14/04/2023 Kerry Cullinan The US Justice Department and Danco Laboratories, the manufacturer of the abortion pill mifepristone, turned to the country’s Supreme Court on Friday to overturn the limits set on access to the drug by lower courts. This follows a partly unsuccessful appeal by the two parties for the stay of a ruling last week by Texas […] Continue reading -> DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
DNDi Offers Model for Pandemic Accord Negotiators on How Governments Can Leverage Drug R&D Investment 13/04/2023 Kerry Cullinan When governments invest in drug research and development (R&D) with pharmaceutical companies, they should ensure upfront that these drugs are affordable and widely available – and a global pandemic accord needs to provide high-level guidance on how to do this. This is the view of the Drugs for Neglected Diseases initiative (DNDi), a non-profit group […] Continue reading -> Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
Fully Funded HIV Response Will Decrease New Infections by 40% to 90% 13/04/2023 Megha Kaveri Ensuring that the HIV responses in countries receive full funding will not only lead to a 40% to 90% reduction in new infections but also result in substantial social and economic benefits, a new report launched by UNAIDS said. The socio-economic benefits countries with a fully financed HIV response will gain are higher educational outcomes, […] Continue reading -> Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
Rape Survivors in DRC and Guinea Get Help in Their Struggle for Justice and Health 12/04/2023 Kizito Makoye KIGOMA, Tanzania – Mary Akile is still harbouring emotional suffering four years after a rape attack that inflicted both physical pain and untold mental anguish. “I still remember how the attackers invaded my house and raped me, one after another,” says Akile, her voice cracking as she recalled the harrowing ordeal during April 2019 at […] Continue reading -> US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts
US Abortion Pill Ruling Could Have Chilling Effect on Other Drug Approvals 11/04/2023 Kerry Cullinan Hundreds of executives from US pharmaceutical and biotech companies have condemned as “judicial activism” last Friday’s ruling by a US District judge in Texas that the Food and Drug Administration (FDA) had erred by approving the abortion pill, mifepristone. The FDA, US Department of Justice and the drug manufacturer, Danco Laboratories have opposed the ruling, […] Continue reading -> Posts navigation Older postsNewer posts